ArticleThe Biochemical journal2023

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.

Catia L Pierotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.